US Tariff Threat May Hit Indian Pharma Earnings by Up to 10%: SBI Research Warns
SBI Research warns that a planned 50% tax on Indian pharmaceutical exports could cut profits and hurt India's important role in the global supply...
The US tariff war gives the Indian pharmaceutical industry a little break
As US President Donald Trump announces new tariffs, India's pharmaceutical industry is safe—for now—showing how important it is to American healthcare.New Delhi, India -...
